Investment Objective
To achieve long term capital appreciation by investing solely in the Invesco Pooled Investment Fund - Europe Fund which is an APIF and in turn invests in European (including the United Kingdom) equities.
Fund Details
Latest Fund Expense Ratio: 1.36%
Launch Date(dd/mm/yyyy): 10/07/2009
Unit Price: HKD 12.4341
Fund Size: HKD 14.44M
Fund Commentary
European equities fell sharply over the quarter as news emerged that the spread of the COVID-19 was accelerating across the western hemisphere. Investors were spooked by fears of an impending global recession as national governments began implementing extreme measures to contain the spread of the virus. Against this backdrop, investors fled stocks in search of safer assets and all sectors of the broad equity market returned negatively. In an emergency meeting, the ECB announced €750bn in asset purchases under a new Pandemic Emergency Purchase Programme (PEPP). The new package came only days after they had already announced a further €120bn of asset purchases at their last scheduled meeting. The PEPP is temporary and set to last till the end of 2020 at least, although can be extended if the COVID-19 crisis persists. Throughout the month, national governments also began to step up their efforts by announcing large fiscal packages to help support the economy while it remains under lockdown. In addition, Angela Merkel also mentioned that Germany would consider joint bonds (‘coronabonds’) to fight the economic impacts of the virus. This would be a significant development given Germany’s previously strict stance on cross border/joint issuance debt.
Fund Performance Information
Annualised return |
Calendar year return |
1 year (p.a. %) |
5 years (p.a. %) |
10 years (p.a. %) |
Since launch (p.a. %) |
2015 | 2016 | 2017 | 2018 | 2019 | YTD |
-25.26% |
-5.88% |
1.39% |
2.05% |
-1.02 | -0.18 | 18.95 | -16.28 | 15.10 | N/A |
Fund Performance Information
Annualised return |
1 year (p.a. %) |
5 years (p.a. %) |
Since launch (p.a. %) |
-25.26% |
-5.88% |
2.05% |
Calendar year return |
2015 | 2016 | 2017 | 2018 | 2019 | YTD |
-1.02 | -0.18 | 18.95 | -16.28 | 15.10 | N/A |
Top 10 Holdings
Security name |
Holdings Weight |
Sanofi |
4.95% |
Roche Hldg AG-Genusschein |
4.78% |
UPM-Kymmene Oyj |
3.05% |
Glaxosmithkline Plc |
3.03% |
Bayer AG-Reg |
2.80% |
SAP SE |
2.66% |
BAE Systems Plc |
2.64% |
Deutsche Post AG-Reg |
2.56% |
Novartis Ag-Reg |
2.50% |
Carrefour SA |
2.42% |
Total |
31.39% |
Top 10 Holdings
Security name Holdings Weight |
Sanofi
Holding Weight 4.95%
|
Roche Hldg AG-Genusschein
Holding Weight 4.78%
|
UPM-Kymmene Oyj
Holding Weight 3.05%
|
Glaxosmithkline Plc
Holding Weight 3.03%
|
Bayer AG-Reg
Holding Weight 2.80%
|
SAP SE
Holding Weight 2.66%
|
BAE Systems Plc
Holding Weight 2.64%
|
Deutsche Post AG-Reg
Holding Weight 2.56%
|
Novartis Ag-Reg
Holding Weight 2.50%
|
Carrefour SA
Holding Weight 2.42%
|
Total: 31.39% |
Portfolio Allocation
- • 27.85 UK Equities
- • 20.32 France Equities
- • 10.51 Germany Equities
- • 5.41 Italy Equities
- • 4.73 Netherlands Equities
- • 4.25 Spain Equities
- • 7.28 Switzerland Equities
- • 15.33 Other European Countries Equities
- • 4.31 Cash & Others
The materials provided are for information only and do not constitute as an offer. For investment advice, please consult professional advisors. The information contained in this website has been compiled with considerable care to ensure its accuracy at the date of publication. However, no representation or warranty, express or implied, is made to its accuracy or completeness. MPF.HK shall not be responsible for any consequential effect, nor be liable for any direct, consequential, incidental, indirect loss or damage, howsoever caused, arising from the use of, inability to use or reliance upon any information or materials provided on this website, whether or not such loss or damage is caused by MPF.HK. Links to third party sites are provided for your information only. The content and software of these sites have been issued by third parties. As such, MPF.HK cannot be responsible for the accuracy of information contained in these sites, nor be held liable for any loss or damage arising from or related to their use.